Aberrant Methylation of Yes-Associated Protein (YAP1) as a Potential Biomarker in Breast Cancer

Egyptian Journal of Medical Human Genetics - Egypt
doi 10.1186/s43042-019-0038-x
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Bladder Cancer-Associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2009English

Aberrant NDRG1 Methylation Associated With Its Decreased Expression and Clinicopathological Significance in Breast Cancer

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2013English

BAI1‑associated Protein 2‑like 2 Is a Potential Biomarker in Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Epigenetic Aberrant Hypermethylation of DNA in Endometrial Cancer: Application as a Biomarker

Journal of Cancer Therapy
2011English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Prediction of Breast Cancer Risk by Aberrant Methylation in Mammary Duct Lavage

2004English

The PREX1/Rac Signaling Axis: Potential as a Biomarker and Therapeutic Target in Breast Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2015English

Nonrandom Distribution of Aberrant Promoter Methylation of Cancer-Related Genes in Sporadic Breast Tumors

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy